首批处方落地即触发4900万港元权益金 派格生物(02565.HK)商业化进入价值兑现期

智通财经
Jul 22
【首批处方落地即触发4900万港元权益金 派格生物(02565.HK)商业化进入价值兑现期】智通财经APP获悉,创新药从获批上市到真正产生商业价值,往往还要跨过医院准入、医生处方、渠道覆盖和患者使用等多重门槛。派格生物(02565.HK)自主研发的国家1类创新药派达康®,正在完成这一关键跨越。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10